These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 7763118)
1. Levothyroxine therapy and osteoporosis. An end to the controversy? Wartofsky L Arch Intern Med; 1995 Jun; 155(11):1130-1. PubMed ID: 7763118 [No Abstract] [Full Text] [Related]
2. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone. Sijanovic S; Karner I Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925 [TBL] [Abstract][Full Text] [Related]
3. [Thyroid and osteoporosis]. Földes J; Lakatos P Orv Hetil; 1996 Jun; 137(25):1347-54. PubMed ID: 8757081 [TBL] [Abstract][Full Text] [Related]
4. [Bone metabolism and thyroid disease. Normalized bone metabolism prevents osteoporosis]. Tørring O Lakartidningen; 1993 Jul; 90(28-29):2517-21. PubMed ID: 8326793 [No Abstract] [Full Text] [Related]
5. Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up. Laine CM; Landin-Wilhelmsen K Osteoporos Int; 2017 Jul; 28(7):2247-2250. PubMed ID: 28324131 [TBL] [Abstract][Full Text] [Related]
7. Adverse bone effects during pharmacological breast cancer therapy. Bjarnason NH; Hitz M; Jorgensen NR; Vestergaard P Acta Oncol; 2008; 47(4):747-54. PubMed ID: 18465344 [TBL] [Abstract][Full Text] [Related]
8. Outcome of treating hypothyroidism. Katz S Can Fam Physician; 1993 Dec; 39():2522. PubMed ID: 8292924 [No Abstract] [Full Text] [Related]
9. [Inhibition of progression of decreasing bone mass and manifest osteoporosis]. Ringe JD Internist (Berl); 1993 Apr; 34(4):300-6. PubMed ID: 8486473 [No Abstract] [Full Text] [Related]
14. Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis. Cauza E; Etemad M; Winkler F; Hanusch-Enserer U; Partsch G; Noske H; Dunky A J Clin Pharm Ther; 2004 Oct; 29(5):431-6. PubMed ID: 15482386 [TBL] [Abstract][Full Text] [Related]
15. Anabolic steroids in corticosteroid-induced osteoporosis. Adami S; Rossini M Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456 [TBL] [Abstract][Full Text] [Related]
16. [Use of bisphosphates in treatment of primary and secondary osteoporosis]. Olszyński WP Pol Tyg Lek; 1995 Nov; 50(44-47):56-8. PubMed ID: 8643431 [TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid for cancer therapy--induced and postmenopausal bone loss. Brufsky AM Expert Opin Pharmacother; 2008 Apr; 9(6):1013-28. PubMed ID: 18377343 [TBL] [Abstract][Full Text] [Related]
18. [Can substitution therapy with thyroxine cause osteoporosis?]. Falch JA Tidsskr Nor Laegeforen; 1992 Jan; 112(2):260-1. PubMed ID: 1566270 [No Abstract] [Full Text] [Related]
19. The role of vitamin D in the pathogenesis and treatment of osteoporosis. Gallagher JC J Rheumatol Suppl; 1996 Aug; 45():15-8. PubMed ID: 8856646 [TBL] [Abstract][Full Text] [Related]